November 2017

The institute began its journey as a family planning unit in 1954 at the ICRC (Later named as Cancer Research Unit). In 1956, the unit was reorganized as the Contraceptive Testing Unit (CTU). Within 5 years of its inception, the Institute broadened the spectrum of its activities and was therefore renamed as Reproductive Physiology Unit (RPU).

The DIPSAR is one of the best Pharmacy Institute in India, with a strength of approximately 500 students, situated on a beautiful 10 acre campus in South Delhi. The institute is experiencing a fast academic growth and commitment to the challenges of the 21s' century.

The Indian Pharmacopoeia commission (IPC) is an Autonomous Body under Ministry of Health & Family, Welfare, Govt of India primarily with the objective of standard setting of drugs.

In order to carry out the obligation under NCC PvPI, Indian Pharmacopoeia Commission intense to encourage personnel, on contract basis on consolidated remuneration having qualification (including exp).

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Research Scientist

Pulla Reddy Institute of Pharmacy is one of the leading colleges of pharmacy which was established in the year 2007. The college was founded and is governed by Gayathri Educational Society which itself was founded in 2004 with an aim to provide quality education to the economical and geographically underprivileged population. The college is affiliated to Osmania University, Andhra Pradesh.

NATIONAL BRAIN RESEARCH CENTRE (NBRC) invites application for the position of “Junior Research Fellow (Project)” in DBT funded project entitled “CRISPRI system: A toolbox to investigate novel regulatory mechanisms of synapse formation by long non-coing RNAs”.

Over the years Sentiss Pharma (erstwhile known Promed group) has positioned itself as the No 3 Ophthalmic Company* in Russia and has expanded its foothold in the US and European markets.
Our key competitive advantage lies in having the R&D center together with the world class manufacturing facility that has enabled us to provide end-to-end solutions from product development to marketing. Our manufacturing facility at Nalagarh (India) is EU GMP certified and TGA (Australia) approved.